Regional health information exchanges with clinical event notification services have the potential to improve care coordination and possibly reduce unnecessary inpatient admissions and duplicate testing, according to a study in Generating Evidence & Methods to improve patient outcomes.
Regional health information exchanges with clinical event notification services have the potential to improve care coordination and possibly reduce unnecessary inpatient admissions and duplicate testing, according to a study in Generating Evidence & Methods to improve patient outcomes.
CENs alert appropriate stakeholders when a patient experiences one of a preset list of clinical events, such as an emergency department admission. The CEN service in this study, incorporated in Healthix, an HIE for the metro New York City area, includes several features the researchers believe to be unique — the CEN system sends alerts through multiple channels including email, text messages and EHR inboxes, as well as automatically entering the encounter into the patient's EHR.
Read the full story: http://bit.ly/VSDw62
Source: Becker’s Hospital Review
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More